As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...

After writing dozens of GLP-1 articles over the past year, one issue that consistently comes up is the affordability of ...

Hims & Hers Health, Inc. could see more upside in partnerships and international expansion. Click here to read an analysis of ...

Novo Nordisk is under pressure from cheap copycats, a Trump pricing deal, and Lilly's fast-growing Zepbound juggernaut.

Zydus Lifesciences Ltd and Torrent Pharmaceuticals Ltd are preparing to enter the fast-growing market for Semaglutide — a ...

Pennsylvanians deserve better than counterfeit medicine cooked up in back rooms and peddled through predatory online ads.

Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded ...

Those weight loss drugs that have been so out of reach for many, may soon be affordable, even if you don't have insurance.

The anti-obesity drug registered sales of ₹100 crore in October, unseating the previous best-selling antibiotic Augmentin, ...

A small new study suggests that people who’ve used GLP-1 drugs to reach a healthy weight can spread out their injections without regaining lost pounds.

How long would you need to jab yourself...and contend with the cost? Two MDs specializing in weight loss and endocrinology share how it works.

Weight-loss medicines like Semaglutide (GLP – 1RA), originally developed to help people with type 2 diabetes manage their ...